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Measuring the spatial 
heterogeneity on the reduction of 
vaginal fistula burden in Ethiopia 
between 2005 and 2016
Kebede Deribe  1,2*, Claudio fronterre  3, Tariku Dejene4, Sibhatu Biadgilign  5, 
Amare Deribew  6,7, Muna Abdullah8 & Jorge cano9
Vaginal fistula is a shattering maternal complication characterized by an anomalous opening between 
the bladder and/or rectum and vagina resulting in continuous leakage of urine or stool. Although 
prevalent in Ethiopia, its magnitude and distribution is not well studied. We used statistical mapping 
models using 2005 and 2016 Ethiopia Demographic Health Surveys data combined with a suite of 
potential risk factors to estimate the burden of vaginal fistula among women of childbearing age. 
The estimated number of women of childbearing age with lifetime and untreated vaginal fistula in 
2016 were 72,533 (95% CI 38,235–124,103) and 31,961 (95% CI 11,596–70,309) respectively. These 
figures show reduction from the 2005 estimates: 98,098 (95% CI 49,819–170,737) lifetime and 59,114 
(95% CI 26,580–118,158) untreated cases of vaginal fistula. The number of districts having more than 
200 untreated cases declined drastically from 54 in 2005 to 6 in 2016. Our results show a significant 
subnational variation in the burden of vaginal fistula. Overall, between 2005 and 2016 there was 
substantial reduction in the prevalence of vaginal fistula in Ethiopia. Our results help guide local level 
tracking, planning, spatial targeting of resources and implementation of interventions against vaginal 
fistula.
Vaginal fistula (VF), which is categorised as vesicovaginal or rectovaginal fistula, occurs when there is abnormal 
opening (fistula) between the bladder and/or the rectum and the vagina1. It is most common in developing coun-
ties and often occurs after protracted obstructed labour, hence it is referred as obstetric fistula. The condition is 
highly debilitating and stigmatizing; women suffering from vaginal fistula are often stigmatized2–4. VF is a disease 
deeply embedded in poverty, harmful practices such as early marriage and inequalities in access to health care. 
Obstetric fistula is virtually unheard of in developed countries.
Campaign to End Obstetric Fistula was launched in 2003 by The United Nations Population Fund and its 
implementing partners that sets an agenda for ‘the elimination of obstetric fistula’ in high burden countries5. In 
line with this global commitment, Ethiopia have targeted to eliminate obstetric fistula by 20206. Data for VF are 
available at the national level in Africa but there is little information about subnational variations1,7,8. Although 
a few studies have reported prevalence of vaginal fistula at specific sites1,7,9,10, no studies have examined vaginal 
fistula prevalence at fine spatial resolution for entire countries. Analysis at country level, although useful for advo-
cacy, may mask subnational geographical variation, which is critical for subnational level planning and measure-
ment of inequalities in a country.
Some studies have been carried out at sub-national level of Ethiopia to establish the burden of obstetric fistula 
(OF). A study conducted in East Hararghe, South Gondar and West Gojjam over a randomly selected sample of 
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23,023 women of childbearing age (WCA) (15–49 years) sampled from 113 villages determined the prevalence of 
OF to be 0.6 per 1,000, of untreated fistula 0.2 per 1,000 and of symptomatic pelvic organ prolapse 10 per 1,000 
of WCA9. Another study included a total of 19,153 households from seven regions of Ethiopia. Untreated fistula 
prevalence was estimated at 1.5 per 1,000 WCA. The authors extrapolated their findings and roughly estimated 
that there were 26,819 women with untreated fistula in Ethiopia10. Finally, another study based on data collected 
through Demographic and Health (DHS) surveys in 2005 estimated the life time and point prevalence of vaginal 
fistula to be 7.1 (5.5–8.7) and 5·6 (4·3–7·0) per 1,000 WCA, respectively7. Although all the above studies contrib-
uted to the body of literature, none of them comprehensively reported local distribution and burden of fistula in 
the country. In addition, the statistics presented by these studies were based on raw collected data and did not 
account either for potential risk factors or for ongoing interventions, which have been conducted over the last 
decade and may have contributed to reduce the burden of vaginal fistula in Ethiopia.
The health system and health services in Ethiopia are devolved to regions and district level (woredas). 
Therefore, reliable data on the prevalence and burden of OF at district level is imperative for planning and action. 
However, such kind of data is lacking in Ethiopia despite the clear socio-economic difference in differ geogra-
phies7,8. We aimed to assess the prevalence and burden of VF at subnational level and understand the geograph-
ical inequalities in the burden of VF. The 2005 and 2016 Ethiopian DHS data were extracted to estimate the 
prevalence and burden of VF in Ethiopia and trend in its distribution over time. Using georeferenced survey data 
and continuous surfaces of potential social determinants of vaginal fistula, we intended to provide estimates of 
vaginal fistula prevalence at a resolution as much as 1 square-km.
Results
General description. Ethiopian DHS for 2005 and 2016 collected data from 14,070 and 15,683 WCA, respec-
tively. Table 1 shows the number of women with vaginal fistula symptoms and the number who have not been 
treated for this condition by region. There was no significant difference in the median of prevalence of untreated 
fistula between rural and urban communities across regions neither in 2005 (Wilcoxon’s test, p-value = 0.7545) 
nor in 2016 (Wilcoxon’s test, p-value = 0.1843). Neither was there significant difference in the median of preva-
lence of lifetime fistula between rural and urban communities in 2005 (Wilcoxon’s test, p-value = 0.439), although 
prevalence was found to be higher in rural than urban areas in 2016 (Wilcoxon’s test, p-value < 0.05). When we 
compared the prevalence of lifetime fistula in rural and urban areas between years, we observed no difference in 
the prevalence in rural areas (Wilcoxon’s test, p-value = 0.3381) whereas the prevalence in urban areas declined 
sharply from 2005 to 2016 (Wilcoxon’s test, p-value < 0.05). However, the prevalence of untreated fistula declined 
significantly both in rural and urban areas (Wilcoxon’s test, p-value < 0.05) in 2016.
Estimated burden of vaginal fistula. The Figs. 1 and 2 shows a heterogeneous spatial distribution and 
number of cases of lifetime and untreated VF in Ethiopia. The highest prevalence of VF for 2005 is estimated in 
some parts of Amhara, Oromia, Southern Nations, Nationalities, and Peoples (SNNP) and Tigray regions. The 
predicted map showed a significant reduction of lifetime and untreated fistula in 2016, although this reduction is 
spatially heterogeneous.
In 2005 the prevalence of life time fistula in Ethiopia was 7.6 cases per 1000 WCA (95% CI: 3.7–13.7). 
Prevalence varied between regions, from 2.7 (95% CI: 1.2–5.3) in Harari, to 15.4 (95% CI: 5.9–32·4) in Tigray 
(Table 2). In 2016 the prevalence of lifetime fistula in Ethiopia was nearly halved the estimated prevalence in 2005, 
3.4 cases per 1000 WCA (95% CI: 1.8–6.0), although the magnitude of reduction varied between regions. This was 
more significant in regions that showed the highest estimated prevalence such as Tigray (from 15.4 to 3.20 per 
1000), Amhara (from 9.2 to 4.1 per 1000), Beneshangul Gumuz (from 9.4 to 3.8 per 1000) or Dire Dawa (from 9.1 
to 2.9 per 1000). Harari, with the lowest estimated prevalence in 2005 (2.7, 95% CI: 1.2–5.3), however, showed no 
significant reduction in the estimated prevalence of lifetime fistula in 2016 (2.5, 95% CI: 1.3–4.4) (Tables 2 and 3).
Region
2005 2016
Total 
interviewed (n)
Women reporting 
vaginal fistula 
symptoms (n)
Untreated 
cases of vaginal 
fistula
Total 
interviewed (n)
Women reporting 
vaginal fistula 
symptoms (n)
Untreated 
cases of vaginal 
fistula
Tigray 1257 14 10 1682 19 4
Afar 789 5 3 1128 6 1
Amara 1943 8 1 1719 12 9
Oromia 2230 20 17 1892 4 1
Somali 669 1 1 1391 5 1
Benishangul Gumuz 846 4 3 1126 7 4
SNNP 2087 26 19 1849 6 2
Gambella 729 5 1 1035 3 2
Harari 844 1 1 906 0 0
Addis Ababa 1869 14 7 1824 7 4
Dire Dawa 807 5 4 1131 1 0
14070 103 67 15683 70 28
Table 1. Number of women of childbearing age surveyed in DHS 2005 and DHS 2016.
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The prevalence of untreated VF symptoms was estimated as 4.8 cases per 1000 WCA (95% CI: 2.1–10.1) in 
2005 (Table 2). There has been a significant reduction to 1.4 cases per 1000 (95% CI: 0.5–3.2) in 2016 (Table 3). 
The highest prevalence of untreated vaginal fistula in 2016 was found in Amhara region with 2.3 cases per 1000 
WCA (95% CI: 0.9–4.7), while Harari had registered the lowest prevalence of untreated fistula in Ethiopia with 
0.6 cases per 1000 WCA (95% CI: 0.2–1.4) (Table 3).
We estimated the number of WCA who had ever had VF symptoms to be 98,098 (95% CI: 49,819–170,737) 
in 2005 (Table 4) and 72,533 (95% CI: 38,235–124,103) in 2016 (Table 5). We have also estimated the number of 
WCA with current VF symptoms to be 59,114 (95% CI: 26,580–118,158) in 2005 (Table 4) and 31,961(95% CI: 
11,596–70,309) in 2016 (Table 5). Oromia, Amhara and SNNP bear the highest burden of WCA who had ever had 
VF symptoms and women who presently had symptoms of VF. The lowest burden of current symptoms of VF was 
predicted in Harari, Gambella and Dire Dawa (Tables 4 and 5).
Based on our models, the estimated prevalence of untreated vaginal fistula only exceeded 20 per 1000 child-
bearing age women in two districts of both Tigray and Amhara regions in 2005, and no single district was 
Figure 1. Predicted mean prevalence of untreated vaginal fistula in 2005 (a) and 2016 (b) across Ethiopia. 
Prevalence is provided in cases per 1,000 women of child bearing age.
Figure 2. Estimated number of childbearing women (15–49 year-old) suffering from untreated vaginal fistula 
in 2005 (a) and in 2016. (b) Figures have been obtained using the estimated number of females aged between 15 
and 49 per sq-km estimated by the WorldPop project.
4Scientific RepoRtS |          (2020) 10:972  | https://doi.org/10.1038/s41598-020-58036-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
Predicted Prevalence per 1,000
Untreated vaginal Fistula Lifetime vaginal Fistula
Lower 
Bound Mean
Upper 
Bound
Lower 
Bound Mean
Upper 
Bound
Addis Ababa 0.46 1.66 4.34 1.65 4.93 9.76
Afar 1.96 3.73 6.73 2.70 4.64 7.47
Amhara 2.19 5.42 12.00 4.38 9.21 16.99
Beneshangul Gumuz 2.55 5.52 10.58 5.05 9.43 15.82
Dire Dawa 2.95 6.31 12.01 4.86 9.06 14.94
Gambella 2.16 4.84 10.60 3.95 7.78 15.20
Harari 0.65 1.84 4.35 1.20 2.70 5.27
Oromia 2.09 3.99 7.21 3.27 5.66 9.09
SNNP 2.59 5.84 11.94 4.53 8.86 15.79
Somali 2.36 4.50 8.43 3.09 5.39 8.57
Tigray 2.72 9.00 23.33 5.95 15.39 32.39
Total Averaged 2.06 4.79 10.14 3.69 7.55 13.75
Table 2. Predicted mean prevalence and credible intervals of vaginal fistula in Ethiopia by 2005.
Predicted Prevalence per 1,000
Untreated vaginal Fistula Lifetime vaginal Fistula
Lower 
Bound Mean
Upper 
Bound
Lower 
Bound Mean
Upper 
Bound
Addis Ababa 0.15 1.43 5.25 0.80 3.09 7.49
Afar 0.62 1.59 3.32 2.24 3.96 6.45
Amhara 0.87 2.27 4.67 2.24 4.11 6.74
Beneshangul Gumuz 0.73 1.70 3.37 2.26 3.80 5.95
Dire Dawa 0.34 0.85 1.70 1.72 2.95 4.62
Gambella 0.36 1.06 2.73 1.62 3.24 6.01
Harari 0.19 0.61 1.45 1.30 2.52 4.38
Oromia 0.56 1.38 2.75 2.05 3.49 5.43
SNNP 0.57 1.54 3.31 1.99 3.59 5.94
Somali 0.48 1.34 3.13 1.92 3.71 6.57
Tigray 0.37 1.23 3.16 1.53 3.20 6.01
Total Averaged 0.48 1.36 3.17 1.79 3.42 5.96
Table 3. Predicted mean prevalence and credible intervals of vaginal fistula in Ethiopia by 2016.
Estimated 19–49-y-old women 2005
Untreated vaginal Fistula Lifetime vaginal Fistula
Lower 
Bound Mean
Upper 
Bound
Lower 
Bound Mean
Upper 
Bound
Addis Ababa 314 1,339 3,773 1,281 4,254 8,801
Afar 556 1,065 1,883 816 1,416 2,265
Amhara 7,392 16,167 31,761 14,314 27,458 46,901
Beneshangul Gumuz 426 923 1,757 847 1,584 2,650
Dire Dawa 131 427 1,085 381 1,111 2,202
Gambella 129 288 637 239 475 930
Harari 15 46 103 37 87 165
Oromia 8,213 16,616 30,688 14,445 26,042 42,552
SNNP 6,333 15,051 30,974 12,134 24,599 43,999
Somali 1,663 3,228 6,065 2,210 3,915 6,369
Tigray 1,408 3,965 9,432 3,114 7,157 13,902
Total 26,580 59,114 118,158 49,819 98,098 170,737
Table 4. Estimated childbearing age women affected by vaginal fistula by 2005.
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estimated to exceed this prevalence in 2016 (Fig. 3). When exploring the burden of vaginal fistula by district, we 
found that the number of districts that were estimated to have more than 200 cases of untreated vaginal fistula 
dropped from 54 in 2005 to 6 in 2016. The majority of the districts with untreated cases were located in Amhara, 
Tigray, SNNP and eastern Oromia Regions (Fig. 4).
In 2016 lifetime VF prevalence of ranged from 2.3 per 1000 in Endegagn district (SNNP Region) to 6.7 per 
1000 in Sigmo district (Oromia Region; Supplementary Information). In 2005 more than 10 per 1000 WCA 
experienced life time VF in Ethiopia in 105 districts in Ethiopia. In 2016 in none of the district registered >10 
per 1000 WCA lifetime VF (Supplementary Information). In 2005 more than 10 per 1000 women of reproductive 
age experienced life time fistula in Ethiopia in 29 districts. In 2016 in none of the districts >10 per 1000 WCA life 
time VF was registered (Fig. 3).
Model validation. We provide in a supplementary information (Figs. S9 and S10) the output of our valida-
tion procedure for the binomial mixed models as described under methods section. We simulated 500 data set 
from the fitted model and calculated the mean and standard deviation. We then compared the distribution of 
these two statistics with the ones observed in the data. For both lifetime and untreated OF models, there is agree-
ment between the simulation from our models and the metrics observed in the empirical data, indicating a good 
predictive performance of the fitted models.
Estimated 19–49-y-old women 2016
Untreated vaginal Fistula Lifetime vaginal Fistula
Lower 
Bound Mean
Upper 
Bound
Lower 
Bound Mean
Upper 
Bound
Addis Ababa 117 1,301 4,928 733 3,261 8,475
Afar 186 473 995 805 1,410 2,267
Amhara 4,250 11,200 23,415 11,490 21,308 35,112
Beneshangul Gumuz 134 307 595 455 759 1,175
Dire Dawa 27 234 826 189 705 1,777
Gambella 37 98 230 158 295 517
Harari 7 48 172 58 178 431
Oromia 3,882 9,822 19,975 13,521 23,674 37,784
SNNP 2,103 5,813 12,487 7,118 13,401 22,716
Somali 463 1,298 2,998 1,994 3,828 6,689
Tigray 390 1,366 3,688 1,715 3,715 7,159
Total 11,596 31,961 70,309 38,235 72,533 124,103
Table 5. Estimated childbearing age women affected by vaginal fistula by 2016.
Figure 3. Predicted mean prevalence of untreated vaginal fistula by district in 2005 (a) and 2016 (b) across 
Ethiopia. Prevalence is provided in cases per 1,000 women of child bearing age.
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Discussion
This is the first geostatistical analysis to estimate the burden of VF at district level in a developing country setting. 
We used large scale survey data in combination with socio-economic, demographic and health related continu-
ous data to obtain these estimates. The point and life time prevalence of VF exhibited considerable heterogeneity 
across districts. The prevalence of symptoms of vaginal fistula although decreasing, still is considerably high. 
Districts with high prevalence are clustered in Amhara, Oromia and SNNP Regions. According to our estimates, 
in 2016, there were 31,961 (95% CI: 11,596–70,309) untreated cases of VF in Ethiopia, with majority of the cases 
in Oromia, Amhara and SNNP and with reduction from 2005 of 72,533 (95% CI: 38,235–124,103) untreated 
cases.
The point prevalence of VF, 1.4 per 1000 WCA, is higher than the prevalence reported by Ballard9 and col-
leagues (0.2 untreated fistula prevalence per 1000 WCA), and consistent with the 1.5 per 1000 WCA reported by 
Muleta and colleagues10 and global estimates for Sub-Saharan (1–1.6 per 1000 WCA)7,8. The point prevalence of 
VF estimates in 2005 was slightly lower than a previous estimation which used the same data sets7. The difference 
between the two estimations is attributed to the definition of treated cases. We assumed all women who reported, 
“having received treatment”, regardless of the outcome of the treatment, as treated cases. The previous analysis 
considered those women who did not report the outcome of the treatment as untreated cases.
We estimated that there were 31,961 (95% CI: 11,596–70,309) cases of untreated women with vagina fistula 
symptoms and 72,533 (95% CI: 38,235–124,103) lifetime vaginal fistula in 2016. There is a significant reduction 
from 2005 figures. The reduction in the prevalence of fistula between 2005 and 2016 could be explained by the 
introduction of health extension workers (HEW) at the community level, which facilitated identification, and 
referral of women with symptoms of vaginal fistula. It could also be attributed to the government’s ambitious 
National Action Plan launched in 2014 to eliminate fistula in six years’ time11.
The results also clearly show that vagina fistula is a ubiquitous and spatially heterogeneous health problem 
in Ethiopia. There is clear clustering of vagina fistula symptoms in some districts. Districts with high burden of 
untreated vagina fistula symptoms include Fareta, Ebenat and Dessie Zuria at the Amhara region. The number 
of untreated VF cases varies between districts from 0 to 291. Arguably, districts in the central Amhara, Oromia, 
and northern SNNP are the areas, which bear the highest burden of VF. These districts required more attention to 
reduce the burden of VF in the country. Districts surrounding Hawassa have to some extent access to emergency 
obstetric care. Thus, it is important to investigate the reason why these districts have high prevalence despite 
having access to emergency obstetric care. To achieve the elimination of obstetric fistula, the highest burden 
districts should primarily be targeted to clear the existing backlog of VF symptoms. In addition, investigating 
district-specific determinants with focus to high burden districts is warranted.
The strength of our analysis include use of large surveys with well powered sample size, covering large geo-
graphical areas and population groups and the use of standardize questionnaire for measuring VF. We generated 
estimates at district level. District level data allows benchmarking of subnational administrative units, which will 
help identify best and worst performing districts and design tailored interventions for the different scenarios. 
However, we must acknowledge some limitations of our analysis. First, VF symptoms is a highly stigmatizing 
condition so that substantial number of women suffering from this condition might have been expelled from 
their homes due to ostracism by their families and seek refuge in long term care facilities dedicated to patients 
with fistula. Considering that DHS is a household based survey, the aforementioned scenarios may lead to many 
Figure 4. Estimated number of childbearing women (15–49 year-old) suffering from lifetime vaginal fistula 
by district in 2005 (a) and in 2016. (b) Figures have been obtained using the estimated number of females aged 
between 15 and 49 per sq-km estimated by the WorldPop project.
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cases not being recorded and therefore the point prevalence be underestimated7,12. Second, the DHS surveys 
only target WCA for self-reported vaginal fistula, although previous studies have documented low incidence 
of vaginal fistula among women older than age 50 years and those younger than 15 years7. This can also lead to 
underestimating the prevalence of VF. Finally, measurement bias could be another limitation13,14 nonetheless, we 
have accounted for sensitivity and specificity of the DHS questionnaire based on previous studies7,13,15. However, 
we do not believe that these limitations diminish the overall interpretations, program and policy implications and 
actions based on our findings.
Our findings also highlight the importance of tracking symptoms of vaginal fistula at granular level for mon-
itoring and programme evaluation. These can be achieved through collection such data through HEW at regular 
interval or through routine community based surveillance at district level. Our findings have several importance 
for policy and programming. First, the findings here will be of help in benchmarking district level burden of VF, 
support monitoring current and future interventions against this condition. Second, identifying districts with 
high burden of VF will help prioritize target areas for intervention and optimize resource allocation. By address-
ing district with high burden districts, the country can speed up the elimination of VF. In addition, program 
planners could identify district level interventions based of the burden of VF.
Third, identification of district with low and high burden VF would open an important research avenue for 
social and behavioural scientist. Comparative studies on identifying contextual and sociocultural factors that 
contribute to low and high prevalence of VF will have important implications in addressing the root causes of 
VF as it has been in other studies16–18. Finally, we have demonstrated how spatial analysis can be used to estimate 
geographical disparity of the burden of vaginal fistula across Ethiopia. Similarly, this framework has the potential 
to be effectively integrated in the national health information system to track burden of other health conditions 
in the country.
In conclusion, our estimates have proven a sharp reduction of the VF between 2005 and 2016 in Ethiopia7. 
The number of districts with >200 cases of untreated vaginal fistula reduced from 54 in 2005 to 6 in 2016. The 
difference could be due to the improved health system and maternal health services, the increased availability 
and accessibility of surgical services and specific efforts to end fistula in the country. Despite the progress made, 
there are still significant number of untreated cases in the country. Therefore, decentralized efforts targeting high 
burden districts is required to stop fistula being a public health problem. Elimination of obstetric fistula by 2020 
as stipulated in the Health Sector Transformation Plan of Ethiopia11 is off track and effort should be intensified on 
prevention interventions and treatment of the existing ones. Strong surveillance system to identify old and new 
cases of vaginal fistula and linking them to the needed surgical services should be strengthened by focusing on 
districts with high burden. There is a favourable momentum in Ethiopia to eliminate fistula, identification and 
referral of women with vaginal fistula is tremendously facilitated by the existence of HEW19,20. The huge boost in 
the number of health centres, trained midwives help manage deliveries and avoid obstructed labour that causes 
obstetric fistula; expansion of hospitals and trained surgical officers over the years have expanded access to fistula 
surgery20,21. Social integration of those who suffered fistula that addresses the physical, mental, social, legal and 
psychological needs of women with this condition is also of paramount importance.
Methods
Data sources. The 2005 and 2016 Ethiopian DHS (EDHS)6,22 provide the largest, most comprehensive vagi-
nal fistula assessment in Ethiopia. The surveys are representative at national and regional level in Ethiopia6,22. The 
surveys included questions that were intended to provide estimates on vaginal fistula6,22.
Administratively, Ethiopia is divided into nine geographical regions and two administrative cities6,22. The 
sample for the EDHS was designed to provide estimates of key indicators for the country, for urban and rural 
areas separately, and for each of the nine regions and the two administrative cities6,22. Each region was stratified 
into urban and rural areas, yielding 21 sampling strata. Samples of enumeration areas (EAs) were selected inde-
pendently in each stratum in two stages6,22. Implicit stratification and proportional allocation were achieved at 
each of the lower administrative levels by sorting the sampling frame within each sampling stratum before sample 
selection, according to administrative units in different levels, and by using a probability proportional to size 
selection at the first stage of sampling6,22.
In the 2005 EDHS, a representative sample of approximately 14,500 households from 540 clusters were 
selected22. The sample was selected in two stages. In the first stage, 540 clusters (145 urban and 395 rural) 
(Supplementary Information, Figs. S1 and S2) were selected from the list of EAs from the 1994 Population and 
Housing Census (PHC) sample frame22. The 2016 DHS was conducted from January 18, 2016, to June 27, 2016 in 
a total of 645 EAs (202 in urban areas and 443 in rural areas) (Supplementary Information; Figs. S3 and S4)6. They 
were selected with probability proportional to EA size (based on the 2007 PHC) and with independent selection 
in each sampling stratum6. All women age 15–49 who were either permanent residents of the selected households 
or visitors who stayed in the household the night before the survey were eligible to be interviewed6.
Measurement of outcomes. We aimed to estimate the district-level lifetime and untreated vaginal fistula 
among WCA and to explore changes overtime. The 2005 and 2016 EDHS included a specific thorough question-
naire of 11 questions intended to diagnose vaginal fistula and to ascertain the severity of the condition6,22. Women 
were asked if they had experienced vaginal fistula as defined by ‘constant leakage of urine or stool from your 
vagina during the day and night6,22?’ Those who reported suffering from vaginal fistula were asked if they had ever 
been treated for this condition6,22. We assessed two main estimates of prevalence following the approach used by 
Maheu-Giroux and colleagues7: (i) lifetime prevalence of fistula, as the proportion of respondents who reported 
having ever had symptoms of vaginal fistula, and (ii), point prevalence (untreated fistula) of fistula symptoms by 
excluding those women who sought treatment for vaginal fistula7.
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Data analysis. Sources of covariates. As it is detailed below, models for lifetime and untreated vaginal fistula 
were constructed using a set of covariates that may potentially be associated with the risk for vaginal fistula7,15,23. 
We considered covariates that were available as continuous gridded maps for the whole country. From the Spatial 
Data DHS Program24, we obtained modelled surfaces of the following covariates indicated to be associated with 
a higher risk for vaginal fistula: (i) percentage of literate women23,25, (ii) proportion of live births in the five (or 
three) years preceding the survey delivered at a health facility4,23,26, (iii) proportion of women using any modern 
method of contraception and iv) proportion of women who had a live birth in the five (or three) years preceding 
the survey who had four or more antenatal care visits15,23 (Figures 5 S & 6 S, Supplementary Information). These 
modelled surfaces are available for Ethiopia at a spatial resolution of 5 km × 5 km and have been produced using 
standardized geostatistical methods, publicly available EDHS data collected in 2016, and a standardized set of 
covariates27.
To account for disparities between rural and urban, we used gridded maps of urban accessibility obtained 
from the European Commission Joint Research Centre Global Environment Monitoring Unit (JRC)28 and from 
the Malaria Atlas project29,30 for 2000 and 2015, respectively (Fig. S6, Supplementary Information). Accessibility 
is time (minutes) taken to travel from a grid cell in the map to a city using land-based travel and employing the 
minimum cost. Cost-distance or impedance was determined by a friction surface that, although generated using 
different sources of data for the 2000 and 2015 accessibility models, in both cases contained information on the 
transport network and environmental and political factors that affect travel times between locations. Further 
details on the generation of this friction surfaces are provided elsewhere28,30. We later used the friction surface 
from 2015 accessibility model to construct a gridded map of distances (kilometres) to the nearest health facility 
(Fig. S5, Supplementary Information). For this, we used a list of health facilities with their geographic coordinates 
downloaded from the Humanitarian Data Exchange database31. This dataset, provided by the Ethiopian Ministry 
of Health, was created in 2012 and is regularly updated. The cost-distance tool available at the Spatial Analyst tool 
from ArcGIS 10.5 (ESRI Inc., Redlands CA, USA) was used to estimate the nearest distance from every cell grid 
in a 5 km × 5 km resolution gridded map from Ethiopia to the nearest health facility.
Population density estimates were obtained from the WorldPop project32 for 2005 and 2015. These estimates 
were used to classify areas as urban (population densities ≥1,000 persons/km2, peri-urban (>250 persons/km2 
within a 15 km distance from urban extents edge)or rural areas (250 persons/km2 and/or >15 km from the urban 
extents edge)2,33 (Fig. S7, Supplementary Information).
Finally, night-light emissivity for 2005 and 2013 (most recent available) captured by the Operational Linescan 
System instrument on board a satellite of the Defence Meteorological Satellite Programme was used as a proxy 
measure of poverty across Ethiopia34,35 (Fig. S7, Supplementary Information). This instrument measures visible 
and infrared radiation emitted at night-time, resulting in remote imagery of lights on the ground. This informa-
tion has been correlated with gross domestic product in developed countries35–37 and, although far from precise, 
would provide an indirect measure of poverty in developing countries38,39.
Input grids were resampled to a common spatial resolution of 1 square-km using a bilinear interpolation 
approach and clipped to match the geographic extent of a map of Ethiopia, and eventually aligned to it35. Raster 
manipulation and processing was undertaken using raster package in in the R software environment35,39,40 and 
final map layouts created with ArcGIS 10.5 software (ESRI Inc., Redlands CA, USA).
We followed a model selection procedure to identify an optimal suite of covariates to include in the fixed 
effects part of the binomial models. In order to reduce any potential collinearity and confounding effects, we first 
grouped the variables and use a formal model selection criterion to select one variable within each of the groups41 
(Tables S1 and S2, Supplementary Information). Variables showing some level of correlation or have similar 
nature (i.e. accessibility and urbanization-related variables) were grouped together. Within each group, we inves-
tigated the relationship between the risks for untreated and lifetime vaginal fistula and each potential explanatory 
variable by fitting univariate models relating the logit of the outcomes to each of the variables41 (Tables S3 and S4, 
Supplementary Information). We compared the univariate models in terms of the Akaike Information Criterion 
(AIC) and selected the model with the lowest value of AIC within each group of variables (Eq. 1). AIC is defined 
as
θ= − +ˆAIC l k2 ( ) 2 , (1)
where θˆl( )  is the maximum log-likelihood function and k is the number of parameters.
Modelling analysis. We estimated district-level prevalence of lifetime and untreated vaginal fistula for 2005 and 
2016 across Ethiopia using a binomial mixed model, accounting for fixed effects (covariates) and random effects, 
for potential unexplained variability between regions42. We chose this method over other analytic approaches 
based on the absence of spatial structure on the prevalence of lifetime and untreated fistula prevalence, explored 
by fitting an empirical variogram42 (Fig. S8, Supplementary Information). Our model used the prevalence esti-
mates and covariates for smoothing the prediction (Eq. 2). Briefly, let Yki denote the random variable associated 
with the number of positively detected cases of lifetime and untreated vaginal fistula at community location xki 
with k indicating the region42. We then modelled Yki using a binomial mixed model with probability of having 
lifetime fistula p(xki) such that35
∑β β



 −




= + +
=
log p x
p x
d x Z( )
1 ( )
( )
(2)
i
i j
j j i i0
1
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where the dj(xi) are geo-referenced covariates (described previously) and the Zk are independent and identically 
distributed zero-mean Gaussian variables with variance σ2. We fitted the model using the lme4 package in the R 
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software environment40,42. Prior to construct the models, observed lifetime and untreated prevalence of vaginal 
fistula at location level were adjusted by assuming a sensitivity and specificity of fistula questionnaires common 
to all surveys of 97% and 99% respectively, as suggested by some authors7,15. Adjustment was implemented as 
suggested by Diggle (2011)43.
Models misspecification and goodness-of-fit were tested by simulating dataset (n = 500) from the fitted mod-
els, and eventually comparing summary statistics computed on the simulated data with the empirical ones. As 
result of good model performance, we expect that our model is able to replicate the characteristics of the observed 
prevalence.
Fitted models were applied on the selected covariates to produce continuous predictions of lifetime and 
untreated vaginal fistula prevalence, predicted mean prevalence and corresponding 95% credible intervals, at 
1 km2 spatial resolutions. Gridded maps of both population density and age structure were obtained from the 
WorldPop project42,44,45. We used this gridded population surface for computing the estimates of affected popula-
tion by pixel by multiplying prevalence of lifetime and untreated vaginal fistula in each square-km area with the 
corresponding population of women of childbearing age (15–49 year-old women) at the same spatial resolution42. 
Using the surfaces, number of women with lifetime and untreated vaginal fistula by district in 2005 and 2016 were 
extracted.
The National Ethics Review Committee of the Ethiopia Science and Technology Commission in Addis Ababa, 
Ethiopia and the ORC Macro Institutional Review Board in Calverton, USA approved the DHS 2005 study pro-
tocol22. The Federal Democratic Republic of Ethiopia Ministry of Science and Technology and the Institutional 
Review Board of ICF International reviewed and approved the DHS Ethiopia 2016 survey protocol6. Informed 
consent was obtained from all participants and/or their legal guardians. All experiments involving human sub-
jects and samples in this study were performed in accordance with relevant guidelines and regulations6,22.
Data availability
The data used in this publication are publicly available from https://dhsprogram.com/data/.
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